Altered Antigen Presentation in Mice Lacking H2-O

Slides:



Advertisements
Similar presentations
Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Advertisements

Volume 49, Issue 1, Pages (January 2006)
Peptide Immunization Indicates that CD8+ T Cells are the Dominant Effector Cells in Trinitrophenyl-Specific Contact Hypersensitivity  Stefan Martin, Michael.
Differentiation of CD4+ T Cells to Th1 Cells Requires MAP Kinase JNK2
Volume 13, Issue 5, Pages (November 2000)
Levels of Polyadenylation Factor CstF-64 Control IgM Heavy Chain mRNA Accumulation and Other Events Associated with B Cell Differentiation  Yoshio Takagaki,
Volume 4, Issue 4, Pages (April 1996)
Volume 6, Issue 5, Pages (May 1997)
Volume 4, Issue 6, Pages (June 1996)
Volume 15, Issue 1, Pages (July 2001)
Volume 11, Issue 5, Pages (November 1999)
Volume 18, Issue 5, Pages (May 2003)
Volume 9, Issue 4, Pages (October 1998)
Volume 11, Issue 2, Pages (August 1999)
Elias T. Spiliotis, Manuel Osorio, Martha C. Zúñiga, Michael Edidin 
Zheng Pu, Scott B Lovitch, Elizabeth K Bikoff, Emil R Unanue  Immunity 
Balthazar B Cazac, Jürgen Roes  Immunity 
Mark H Kaplan, Ulrike Schindler, Stephen T Smiley, Michael J Grusby 
Volume 15, Issue 6, Pages (December 2001)
Volume 13, Issue 3, Pages (September 2000)
Volume 24, Issue 3, Pages (March 2006)
Impaired Development of Th2 Cells in IL-13-Deficient Mice
IL-15Rα Recycles and Presents IL-15 In trans to Neighboring Cells
Volume 24, Issue 5, Pages (May 2006)
Impaired Th2 Subset Development in the Absence of CD4
CD22 is a negative regulator of B-cell receptor signalling
Pax5/BSAP Maintains the Identity of B Cells in Late B Lymphopoiesis
Zheng Pu, Scott B Lovitch, Elizabeth K Bikoff, Emil R Unanue  Immunity 
Regulation of the T-Independent Humoral Response by TACI
Yang Xu, Genhong Cheng, David Baltimore  Immunity 
The Physiologic Role of CD19 Cytoplasmic Tyrosines
Volume 20, Issue 4, Pages (April 2004)
Volume 13, Issue 4, Pages (October 2000)
Volume 22, Issue 4, Pages (April 2005)
Volume 4, Issue 2, Pages (February 1996)
Paul J Lehner, Michael J Surman, Peter Cresswell  Immunity 
Both E12 and E47 Allow Commitment to the B Cell Lineage
Volume 6, Issue 3, Pages (March 1997)
Positive Selection of Dendritic Epidermal γδ T Cell Precursors in the Fetal Thymus Determines Expression of Skin-Homing Receptors  Na Xiong, Chuhlo Kang,
Volume 25, Issue 5, Pages (November 2006)
Volume 4, Issue 4, Pages (April 1996)
Regulation of the T-Independent Humoral Response by TACI
Volume 16, Issue 5, Pages (May 2002)
Altered Antigen Presentation in Mice Lacking H2-O
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
Impaired Development of Th2 Cells in IL-13-Deficient Mice
T Cell–Mediated Elimination of B7.2 Transgenic B Cells
Volume 84, Issue 4, Pages (February 1996)
Ly6d-L, a Cell Surface Ligand for Mouse Ly6d
Volume 19, Issue 4, Pages (October 2003)
CTLA-4 Regulates Induction of Anergy In Vivo
Multiple Developmental Stage–Specific Enhancers Regulate CD8 Expression in Developing Thymocytes and in Thymus-Independent T Cells  Wilfried Ellmeier,
Volume 10, Issue 4, Pages (April 1999)
Volume 10, Issue 2, Pages (February 1999)
TRAF1 Is a Negative Regulator of TNF Signaling
Volume 17, Issue 3, Pages (September 2002)
Volume 7, Issue 3, Pages (September 1997)
Volume 9, Issue 3, Pages (September 1998)
Asymmetric Redundancy in CD4 Silencer Function
Volume 8, Issue 2, Pages (February 1998)
Volume 7, Issue 6, Pages (December 1997)
Volume 4, Issue 2, Pages (February 1996)
Volume 10, Issue 2, Pages (February 1999)
Volume 28, Issue 1, Pages (January 2008)
Elias T. Spiliotis, Manuel Osorio, Martha C. Zúñiga, Michael Edidin 
Analysis of Type 2 Immunity In Vivo with a Bicistronic IL-4 Reporter
Activation of the Lck Tyrosine Kinase Targets Cell Surface T Cell Antigen Receptors for Lysosomal Degradation  Ugo D'Oro, Melanie S Vacchio, Allan M Weissman,
Volume 4, Issue 5, Pages (May 1996)
Control of B Cell Production by the Adaptor Protein Lnk
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
Presentation transcript:

Altered Antigen Presentation in Mice Lacking H2-O Monika Liljedahl, Ola Winqvist, Charles D Surh, Phillip Wong, Karen Ngo, Luc Teyton, Per A Peterson, Anders Brunmark, Alexander Y Rudensky, Wai-Ping Fung-Leung, Lars Karlsson  Immunity  Volume 8, Issue 2, Pages 233-243 (February 1998) DOI: 10.1016/S1074-7613(00)80475-6

Figure 1 Disruption of the Mouse H2-Oa Gene (A) The mouse H2-Oa gene and the knockout construct are shown. A neomycin-resistance gene (neo) was inserted into exon 2 of the H2-Oa gene, and a herpes simplex–thymidine kinase gene (tk) was placed at the 3′ end of the construct. Restriction sites are BamHI (B), EcoRI (E), HindIII (H), NotI (N), SfiI (Sf), and SmaI (Sm). Numbered filled boxes are exons. The probes shown flanking the 5′ and 3′ ends of the construct were used in Southern hybridization to confirm homologous recombinations. (B) Immunoprecipitation from 35S-labeled spleen cells. H2-Oa+/+ (top) or H2-Oa−/− (bottom) splenocytes were labeled for 30 min (a and c) and either analyzed immediately (0 min) or after chase in nonradioactive medium for 240 min (b and d). H2-Oβ was immunoprecipitated from the cell lysates with rabbit antiserum K535 (anti-H2-Oβ) and analyzed by two-dimensional gel electrophoresis. Oαp and Oβp indicate nontransported forms of Oα and Oβ. Acidic proteins are located to the right. (C) Confocal images of H2-Oa+/+ (a and b) or H2-Oa−/− (c and d) splenocytes stained with K535 (a and c) and 2E5A (anti-H2-M) (b and d). (D) Analysis of H2-O and H2-M expression by flow cytometry. B cells from H2-Oa+/+ (fine line) or H2-Oa−/− (bold line) mice were permeabilized with saponin and stained with 2E5A for H2-M (a) or K535 for H2-Oβ (b). The negative control staining (dotted line) was the same in the two types of mice. Immunity 1998 8, 233-243DOI: (10.1016/S1074-7613(00)80475-6)

Figure 1 Disruption of the Mouse H2-Oa Gene (A) The mouse H2-Oa gene and the knockout construct are shown. A neomycin-resistance gene (neo) was inserted into exon 2 of the H2-Oa gene, and a herpes simplex–thymidine kinase gene (tk) was placed at the 3′ end of the construct. Restriction sites are BamHI (B), EcoRI (E), HindIII (H), NotI (N), SfiI (Sf), and SmaI (Sm). Numbered filled boxes are exons. The probes shown flanking the 5′ and 3′ ends of the construct were used in Southern hybridization to confirm homologous recombinations. (B) Immunoprecipitation from 35S-labeled spleen cells. H2-Oa+/+ (top) or H2-Oa−/− (bottom) splenocytes were labeled for 30 min (a and c) and either analyzed immediately (0 min) or after chase in nonradioactive medium for 240 min (b and d). H2-Oβ was immunoprecipitated from the cell lysates with rabbit antiserum K535 (anti-H2-Oβ) and analyzed by two-dimensional gel electrophoresis. Oαp and Oβp indicate nontransported forms of Oα and Oβ. Acidic proteins are located to the right. (C) Confocal images of H2-Oa+/+ (a and b) or H2-Oa−/− (c and d) splenocytes stained with K535 (a and c) and 2E5A (anti-H2-M) (b and d). (D) Analysis of H2-O and H2-M expression by flow cytometry. B cells from H2-Oa+/+ (fine line) or H2-Oa−/− (bold line) mice were permeabilized with saponin and stained with 2E5A for H2-M (a) or K535 for H2-Oβ (b). The negative control staining (dotted line) was the same in the two types of mice. Immunity 1998 8, 233-243DOI: (10.1016/S1074-7613(00)80475-6)

Figure 1 Disruption of the Mouse H2-Oa Gene (A) The mouse H2-Oa gene and the knockout construct are shown. A neomycin-resistance gene (neo) was inserted into exon 2 of the H2-Oa gene, and a herpes simplex–thymidine kinase gene (tk) was placed at the 3′ end of the construct. Restriction sites are BamHI (B), EcoRI (E), HindIII (H), NotI (N), SfiI (Sf), and SmaI (Sm). Numbered filled boxes are exons. The probes shown flanking the 5′ and 3′ ends of the construct were used in Southern hybridization to confirm homologous recombinations. (B) Immunoprecipitation from 35S-labeled spleen cells. H2-Oa+/+ (top) or H2-Oa−/− (bottom) splenocytes were labeled for 30 min (a and c) and either analyzed immediately (0 min) or after chase in nonradioactive medium for 240 min (b and d). H2-Oβ was immunoprecipitated from the cell lysates with rabbit antiserum K535 (anti-H2-Oβ) and analyzed by two-dimensional gel electrophoresis. Oαp and Oβp indicate nontransported forms of Oα and Oβ. Acidic proteins are located to the right. (C) Confocal images of H2-Oa+/+ (a and b) or H2-Oa−/− (c and d) splenocytes stained with K535 (a and c) and 2E5A (anti-H2-M) (b and d). (D) Analysis of H2-O and H2-M expression by flow cytometry. B cells from H2-Oa+/+ (fine line) or H2-Oa−/− (bold line) mice were permeabilized with saponin and stained with 2E5A for H2-M (a) or K535 for H2-Oβ (b). The negative control staining (dotted line) was the same in the two types of mice. Immunity 1998 8, 233-243DOI: (10.1016/S1074-7613(00)80475-6)

Figure 1 Disruption of the Mouse H2-Oa Gene (A) The mouse H2-Oa gene and the knockout construct are shown. A neomycin-resistance gene (neo) was inserted into exon 2 of the H2-Oa gene, and a herpes simplex–thymidine kinase gene (tk) was placed at the 3′ end of the construct. Restriction sites are BamHI (B), EcoRI (E), HindIII (H), NotI (N), SfiI (Sf), and SmaI (Sm). Numbered filled boxes are exons. The probes shown flanking the 5′ and 3′ ends of the construct were used in Southern hybridization to confirm homologous recombinations. (B) Immunoprecipitation from 35S-labeled spleen cells. H2-Oa+/+ (top) or H2-Oa−/− (bottom) splenocytes were labeled for 30 min (a and c) and either analyzed immediately (0 min) or after chase in nonradioactive medium for 240 min (b and d). H2-Oβ was immunoprecipitated from the cell lysates with rabbit antiserum K535 (anti-H2-Oβ) and analyzed by two-dimensional gel electrophoresis. Oαp and Oβp indicate nontransported forms of Oα and Oβ. Acidic proteins are located to the right. (C) Confocal images of H2-Oa+/+ (a and b) or H2-Oa−/− (c and d) splenocytes stained with K535 (a and c) and 2E5A (anti-H2-M) (b and d). (D) Analysis of H2-O and H2-M expression by flow cytometry. B cells from H2-Oa+/+ (fine line) or H2-Oa−/− (bold line) mice were permeabilized with saponin and stained with 2E5A for H2-M (a) or K535 for H2-Oβ (b). The negative control staining (dotted line) was the same in the two types of mice. Immunity 1998 8, 233-243DOI: (10.1016/S1074-7613(00)80475-6)

Figure 2 Characterization of MHC Class II Expression in H2-Oa−/− Mice and H2-O+/+ Littermates (A) Lymph node cells from wild-type (shaded area), H2-Oa−/− (solid line), and H2-M−/− (dotted line) mice were stained with antibodies reactive to H2-Ab (Y3P) or CLIP-containing H2-Ab (30-2 and 15G4) and analyzed by flow cytometry. (B) Serial spleen sections from wild-type, H2-Oa−/−, and H2-M−/− mice were stained for H2-O or H2-M with rabbit antiserum K535 or K553, respectively. Locations of follicles (f), periarteriolar lymphocyte sheath (pals), and germinal centers (gc) are depicted. (C) Immunoprecipitation from 35S-labeled spleen cells. H2-Oa+/+ (left) or H2-Oa−/− (right) splenocytes were labeled for 30 min and then either analyzed immediately (0 min) or after chase in nonradioactive medium for the indicated time (in hours). H2-Ab was immunoprecipitated and samples were analyzed without prior boiling or reduction. Size markers (at left) are in kilodaltons. Immunity 1998 8, 233-243DOI: (10.1016/S1074-7613(00)80475-6)

Figure 2 Characterization of MHC Class II Expression in H2-Oa−/− Mice and H2-O+/+ Littermates (A) Lymph node cells from wild-type (shaded area), H2-Oa−/− (solid line), and H2-M−/− (dotted line) mice were stained with antibodies reactive to H2-Ab (Y3P) or CLIP-containing H2-Ab (30-2 and 15G4) and analyzed by flow cytometry. (B) Serial spleen sections from wild-type, H2-Oa−/−, and H2-M−/− mice were stained for H2-O or H2-M with rabbit antiserum K535 or K553, respectively. Locations of follicles (f), periarteriolar lymphocyte sheath (pals), and germinal centers (gc) are depicted. (C) Immunoprecipitation from 35S-labeled spleen cells. H2-Oa+/+ (left) or H2-Oa−/− (right) splenocytes were labeled for 30 min and then either analyzed immediately (0 min) or after chase in nonradioactive medium for the indicated time (in hours). H2-Ab was immunoprecipitated and samples were analyzed without prior boiling or reduction. Size markers (at left) are in kilodaltons. Immunity 1998 8, 233-243DOI: (10.1016/S1074-7613(00)80475-6)

Figure 2 Characterization of MHC Class II Expression in H2-Oa−/− Mice and H2-O+/+ Littermates (A) Lymph node cells from wild-type (shaded area), H2-Oa−/− (solid line), and H2-M−/− (dotted line) mice were stained with antibodies reactive to H2-Ab (Y3P) or CLIP-containing H2-Ab (30-2 and 15G4) and analyzed by flow cytometry. (B) Serial spleen sections from wild-type, H2-Oa−/−, and H2-M−/− mice were stained for H2-O or H2-M with rabbit antiserum K535 or K553, respectively. Locations of follicles (f), periarteriolar lymphocyte sheath (pals), and germinal centers (gc) are depicted. (C) Immunoprecipitation from 35S-labeled spleen cells. H2-Oa+/+ (left) or H2-Oa−/− (right) splenocytes were labeled for 30 min and then either analyzed immediately (0 min) or after chase in nonradioactive medium for the indicated time (in hours). H2-Ab was immunoprecipitated and samples were analyzed without prior boiling or reduction. Size markers (at left) are in kilodaltons. Immunity 1998 8, 233-243DOI: (10.1016/S1074-7613(00)80475-6)

Figure 3 Antigen Presentation by B Cells and Serum Immunoglobulin Levels (A) Presentation of antigens internalized by fluid phase to T cell hybridoma cells. Highly purified B cells from H2–0+/+ (circles) and H2-O−/− (triangles) mice were incubated with 0–800 μg/ml antigen (up to 400 μg/ml myoglobin) and T hybridoma cells overnight. IL-2 production by the hybridoma cells was measured in culture supernatants by ELISA. (B) Presentation of antigens internalized by mIg-mediated uptake. B cells from transgenic H2–0+/+ (circles) and H2-O−/− (triangles) mice expressing anti-pc antibody were pulsed with pc-conjugated antigens for 1 hr, washed extensively to remove the excess antigen, and incubated with hybridoma cells overnight. Values represent the mean (± SD) IL-2 production from triplicate cultures. Levels of statistical significance between the means using Student's t test are indicated (*P < 0.05; ** P < 0.01; *** P < 0.005). (C) Peptide presentation to HEL hybridoma cells. B cells from H2-O+/+ (circles) and H2-O−/− (triangles) mice were cultured overnight (18 hr) with 0–1 μM HEL peptide (amino acids 74–91) in the presence of the HEL hybridoma. IL-2 production was measured as described above. Immunity 1998 8, 233-243DOI: (10.1016/S1074-7613(00)80475-6)

Figure 4 Immunoglobulin Levels in Sera Sera from 10-month-old sex-matched H2-O+/+ (circles) and H2-O−/− (triangles) mice were titrated and immunoglobulin levels were measured using isotype-specific ELISA. Bars represent mean serum levels expressed as optical density (OD) at 405 nm. Immunity 1998 8, 233-243DOI: (10.1016/S1074-7613(00)80475-6)

Figure 5 Analysis of DO Function In Vitro (A) Kinetics of FITC-HA binding to DR1. DR1 (500 nM) was incubated with FITC-HA peptide (2.5 μM) alone or with the indicated proteins (DM 500 nM, DMDO 500 nM, or DM 500 nM and IgG1 500 nM) for increasing lengths of time at 37°C, pH 5.5. Samples were neutralized and free peptide was separated from DR–peptide complexes by gel filtration. A fluorescence of 100% represents the binding in the presence of DM. (B and C) Kinetics of FITC-CLIP (B) and FITC-HA (C) release from DR1. DR1 preloaded with FITC-labeled peptides was incubated with 5 μM unlabeled HA peptide alone or in the presence of DM (500 nM) or DMDO (500 nM). Samples were treated as described above. Fluorescence is given as the percentage of the initial value. Immunity 1998 8, 233-243DOI: (10.1016/S1074-7613(00)80475-6)

Figure 6 Conformational Changes in DO and DMDO upon Acidification (A) Proteins (at 200 nM) were incubated at the indicated pH. ANS (to 20 μM) was added and fluorescence was measured immediately. (B) DM or DMDO (at 200 nM) were incubated at the indicated pH for 4 hours at 37°C. ANS (to 20 μM) was added and fluorescence was measured immediately. Samples were neutralized and remeasured immediately. Immunity 1998 8, 233-243DOI: (10.1016/S1074-7613(00)80475-6)

Figure 7 Increased Activity of DMDO at Acidic pH (A) CD27Fc, DM, or DMDO (125 nM) was incubated at 37°C for 3 hr at the indicated pH before addition of DR1 (250 nM) and FITC-HA peptide (5 μM). Samples were incubated for 1.5 hr at 37°C and then neutralized and analyzed as in Figure 5. A fluorescence of 100% represents the binding in the presence of DM at pH 5.5. (B) Kinetics of FITC-HA binding to DR1 (500 nM) in the presence of CD27, DMDO, papain-digested DMDO, or in vitro–formed DMDO complexes (DMDO mix), all at 500 nM. Samples were incubated for increasing lengths of time at 37°C at pH 5.5 or pH 4.5 and then analyzed as in Figure 5. A fluorescence of 100% indicates the maximal fluorescence in the presence of DMDO at pH 4.5. (C and D) Kinetics of FITC-HA binding to DR1 (500 nM) in the presence of CD27 (500 nM), DMDO (500 nM), and two dilutions of DM (64 nM and 20 nM) at pH 5.5 (C) or pH 4.5 (D). Samples were incubated at and analyzed as described above. A fluorescence of 100% indicates the maximal fluorescence in the presence of DMDO at pH 4.5. Immunity 1998 8, 233-243DOI: (10.1016/S1074-7613(00)80475-6)